Abstract
Oligonucleotide therapeutics have emerged as a promising class of drugs to treat a wide range of diseases caused by genetic abnormalities. Replacement of the phosphodiester linkage with a phosphorothioate is one of the most successful modifications made to oligonucleotides to enhance their in vivo stability. The longer elimination phase of phosphorothioates and other modified oligonucleotides requires sensitive and selective methods to quantify the parent drug and their metabolites simultaneously. Liquid chromatography tandem mass spectrometry has excellent selectivity between the parent drug and its metabolites and a wide dynamic range. However, the biological sample extraction remains a formidable challenge in developing quantitative LC–MS methods for oligonucleotides. Protein precipitation, protein digestion, liquid–liquid extraction, reversed phase solid phase extraction (SPE), strong anion exchange SPE, and combinations of them have been reported to extract oligonucleotides from biological matrices. Unfortunately, these methods either have low recoveries or present potential problems for applications with chromatography due to the large amount of matrix substances in the resulting solutions. In this study, a weak anion exchange SPE method was optimized. The recovery ranged from 60% to 80% depending on the concentration. This is the first report of a one-step SPE method with recoveries greater than 60% across the method dynamic range. This sample extraction procedure was used in combination with ultrahigh-performance liquid chromatography–tandem mass spectrometry. The lower limit of quantitation was 10 ng/mL (1.3 nM), and the dynamic range was 10–1,000 ng/mL. The intra- and inter-day precision and accuracy were within 8.4% and 10.5%, respectively.
Similar content being viewed by others
References
Paril SD, Rohdes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. 2005;7:1.
Crooke ST. Vitravene—another piece in the mosaic. Antisense Nucleic Acid Drug Dev. 1998;8:vii.
Zhang G, Lin J, Srinivasan K, Kavetskaia O, Duncan JN. Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography–tandem mass spectrometry. Anal Chem. 2007;79:3416.
Bourque AJ, Cohen AS. Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using direct injection fast anion-exchange chromatography and capillary gel electrophoresis. J Chromatogr B. 1994;662:343.
Dai G, Wei X, Liu Z, Liu S, Marcucci G, Chan KK. Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry. J Chromatogr B. 2005;825:201.
Chen SH, Qian M, Brennan JM, Gallo JM. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. J Chromatogr B. 1997;692:43–51.
Bellon L, Maloney L, Zinnen SP, Sandberg JA, Johnson KE. Quantitative determination of a chemically modified hammerhead ribozyme in blood plasma using 96-well solid-phase extraction coupled with high-performance liquid chromatography or capillary gel electrophoresis. Anal Biochem. 2000;238:228–40.
Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the Assessment of matrix effect in quantitative bioanalytical methods based on HPLC−MS/MS. Anal Chem. 2003;75(13):3019–30.
Rudge J, Scott G, Hail M, and McGinley M. Preparation and LC/MS analysis of oligonucleotide therapeutics from biological matrices. Chromatography Today. 2011; March, 16.
McGinnis AC, Chen B, Bartlett MG. Chromatographic methods for the determination of therapeutic oligonucleotides. J Chromatogr B. 2012;883:76–94.
Ni J, Pomerantz SC, McCloskey JA. Rapid sequencing of modified oligonucleotides using tandem mass spectrometry with electrospray ionization. Nucleic Acids Symp Ser. 1996;35:113–4.
Deng P, Chen X, Zhang G, Zhong D. Bioanalysis of an oligonucleotide and its metabolites by liquid chromatography–tandem mass spectrometry. J Pharm Biomed Anal. 2010;52:571–9.
Acknowledgments
The authors thank Scott Krepich of Phenomenex Inc. for his support and help of this work. The author would also like to thank Kelvin Clodfelter from Waters Corp. for the columns used in this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editor: Michael Bartlett
Rights and permissions
About this article
Cite this article
Chen, B., Bartlett, M. A One-Step Solid Phase Extraction Method for Bioanalysis of a Phosphorothioate Oligonucleotide and Its 3′ n-1 Metabolite from Rat Plasma by uHPLC–MS/MS. AAPS J 14, 772–780 (2012). https://doi.org/10.1208/s12248-012-9394-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-012-9394-x